Extendicare (TSE:EXE - Free Report) had its price objective increased by TD Securities from C$10.50 to C$13.00 in a research note issued to investors on Monday morning,BayStreet.CA reports. They currently have a hold rating on the stock.
Several other research analysts have also recently issued reports on the company. Royal Bank of Canada raised their target price on Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a research report on Thursday, November 28th. BMO Capital Markets raised their price objective on shares of Extendicare from C$11.00 to C$13.50 in a report on Monday. Finally, Cormark raised shares of Extendicare to a "moderate buy" rating in a report on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Extendicare currently has a consensus rating of "Hold" and an average target price of C$11.50.
Read Our Latest Stock Analysis on Extendicare
Extendicare Stock Performance
Shares of EXE stock traded down C$0.07 on Monday, reaching C$13.01. The stock had a trading volume of 184,127 shares, compared to its average volume of 186,533. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. Extendicare has a 1 year low of C$6.63 and a 1 year high of C$13.12. The stock has a market cap of C$1.09 billion, a P/E ratio of 16.59 and a beta of 1.26. The company has a 50 day simple moving average of C$10.84 and a 200 day simple moving average of C$9.86.
Extendicare Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 17th will be paid a $0.04 dividend. This represents a $0.48 annualized dividend and a dividend yield of 3.69%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare's dividend payout ratio (DPR) is currently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
